Molecular Imaging Demonstrates Promise for Predicting Complete Pathologic Response in HER2-Positive
October 15, 2026
October 15, 2026
RESTON, Virginia, Oct. 15 [Category: Medical] -- The Society of Nuclear Medicine and Molecular Imaging posted the following news release:
* * *
Molecular Imaging Demonstrates Promise for Predicting Complete Pathologic Response in HER2-Positive
*
Reston, VA (October 15, 2026)--Molecular imaging with 68Ga-HER2 PET/CT may provide an early, targeted measure of how well treatment is working in patients with HER2-positive breast cancer. According to . . .
* * *
Molecular Imaging Demonstrates Promise for Predicting Complete Pathologic Response in HER2-Positive
*
Reston, VA (October 15, 2026)--Molecular imaging with 68Ga-HER2 PET/CT may provide an early, targeted measure of how well treatment is working in patients with HER2-positive breast cancer. According to . . .